Daré Bioscience (DARE) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free DARE Stock Alerts $0.31 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Daré Bioscience Short Interest DataCurrent Short Volume246,900 sharesPrevious Short Volume235,000 sharesChange Vs. Previous Month+5.06%Dollar Volume Sold Short$118,536.69Short Interest Ratio / Days to Cover0.6Last Record DateApril 15, 2024Outstanding Shares100,580,000 sharesPercentage of Shares Shorted0.25%Today's Trading Volume340,284 sharesAverage Trading Volume1,182,168 sharesToday's Volume Vs. Average29% Short Selling Daré Bioscience ? Sign up to receive the latest short interest report for Daré Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDARE Short Interest Over TimeDARE Days to Cover Over TimeDARE Percentage of Float Shorted Over Time Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details Daré Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024246,900 shares $118,536.69 +5.1%N/A0.6 $0.48 3/31/2024235,000 shares $115,197.00 -48.5%N/A0.6 $0.49 3/15/2024456,200 shares $213,684.08 -14.0%N/A1.1 $0.47 2/29/2024530,500 shares $304,507.00 +5.2%N/A0.8 $0.57 2/15/2024504,200 shares $184,385.94 -10.1%N/A0.8 $0.37 1/31/2024560,900 shares $182,292.50 -11.3%N/A1 $0.33 Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024632,000 shares $229,795.20 -27.3%N/A1.1 $0.36 12/31/2023869,800 shares $268,768.20 -11.2%N/A1.6 $0.31 12/15/2023979,200 shares $344,580.48 +76.8%N/A2 $0.35 11/30/2023553,900 shares $193,865.00 +23.9%N/A1.3 $0.35 11/15/2023447,000 shares $152,963.40 -22.6%N/A1.8 $0.34 10/31/2023577,300 shares $247,084.40 +0.9%N/A2.5 $0.43 10/15/2023572,300 shares $263,258.00 -4.7%N/A2.4 $0.46 9/30/2023600,300 shares $277,218.54 +4.8%N/A2.2 $0.46 9/15/2023572,800 shares $292,128.00 -31.6%N/A1.9 $0.51 8/31/2023836,800 shares $572,622.24 +19.4%N/A2.7 $0.68 8/15/2023700,900 shares $515,091.41 +11.6%N/A2.4 $0.73 7/31/2023628,300 shares $469,151.61 -9.3%N/A2.2 $0.75 7/15/2023692,400 shares $602,388.00 +45.1%N/A2.6 $0.87 6/30/2023477,100 shares $434,208.71 +29.4%N/A2.2 $0.91 6/15/2023368,600 shares $353,856.00 +7.6%N/A1.9 $0.96 5/31/2023342,600 shares $346,026.00 -9.5%N/A1.8 $1.01 5/15/2023378,600 shares $382,386.00 -25.9%N/A2 $1.01 4/30/2023511,000 shares $511,000.00 -16.6%N/A2.5 $1.00 4/15/2023612,400 shares $618,524.00 +12.5%N/A2.2 $1.01 3/31/2023544,400 shares $566,176.00 +16.8%N/A1.8 $1.04 3/15/2023466,000 shares $466,000.00 -15.9%N/A1.5 $1.00 2/28/2023554,100 shares $576,264.00 -49.6%N/A1.8 $1.04 2/15/20231,100,000 shares $1.24 million -38.6%N/A3.5 $1.13 1/31/20231,790,000 shares $2.27 million +51.7%N/A5.7 $1.27 1/15/20231,180,000 shares $1.42 million -13.2%N/A5.1 $1.20 12/30/20221,360,000 shares $1.13 million +33.3%N/A5.7 $0.83 12/15/20221,020,000 shares $922,080.00 -12.8%N/A4.1 $0.90 11/30/20221,170,000 shares $1.04 million +4.5%N/A4.5 $0.89 11/15/20221,120,000 shares $1.06 million -0.9%N/A4.1 $0.95 10/31/20221,130,000 shares $1.10 million -8.1%N/A3.8 $0.97 10/15/20221,230,000 shares $1.10 million -12.1%N/A3.7 $0.89 9/30/20221,400,000 shares $1.40 million -0.7%N/A3.6 $1.00 9/15/20221,410,000 shares $1.55 million -3.4%N/A2.2 $1.10 8/31/20221,460,000 shares $1.58 million -2.7%N/A2 $1.08Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. DARE Short Interest - Frequently Asked Questions What is Daré Bioscience's current short interest? Short interest is the volume of Daré Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 246,900 shares of DARE short. Learn More on Daré Bioscience's current short interest. What is a good short interest ratio for Daré Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DARE shares currently have a short interest ratio of 1.0. Learn More on Daré Bioscience's short interest ratio. Which institutional investors are shorting Daré Bioscience? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Daré Bioscience: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Daré Bioscience's short interest increasing or decreasing? Daré Bioscience saw a increase in short interest in April. As of April 15th, there was short interest totaling 246,900 shares, an increase of 5.1% from the previous total of 235,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Daré Bioscience's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Daré Bioscience: Enlivex Therapeutics Ltd. (1.50%), CASI Pharmaceuticals, Inc. (0.99%), JanOne Inc. (1.72%), Theratechnologies Inc. (0.13%), DURECT Co. (3.19%), Fortress Biotech, Inc. (13.02%), Viracta Therapeutics, Inc. (2.50%), Spruce Biosciences, Inc. (0.74%), ImmunoPrecise Antibodies Ltd. (1.58%), NextCure, Inc. (0.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Daré Bioscience stock? Short selling DARE is an investing strategy that aims to generate trading profit from Daré Bioscience as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Daré Bioscience? A short squeeze for Daré Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DARE, which in turn drives the price of the stock up even further. How often is Daré Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DARE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ENLV Short Squeeze CASI Short Squeeze JAN Short Squeeze THTX Short Squeeze DRRX Short Squeeze FBIO Short Squeeze VIRX Short Squeeze SPRB Short Squeeze IPA Short Squeeze NXTC Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DARE) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldCharles Payne Demystifies OptionsUnstoppable ProsperityThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith